Vireo Partners with Einstein Medicine on $3.8M NIH Grant to Study Cannabis in Chronic Pain
Vireo Health, a cannabis company with a strong presence in the state, will be partnering with Albert Einstein College of Medicine and Montefiore Health System to study if medical marijuana can reduce opioid use in patients suffering chronic pain.
The $3.8M was included in a R01 grant from the NIH. Chinazo Cunningham, a physician and researcher interested in drug use and HIV, is the principal investigator on the study.
The study plans to include 250 HIV positive and negative adults that certified for medical marijuana. The 18-month study will assess pain levels, medical and illicit use of marijuana and opioids, and perception of how marijuana use affects opioid use.